STOCKHOLDERS' EQUITY, Equity Incentive Plans (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 21, 2022
Stock Options [Abstract]
Common stock, available for issuance (in shares)	29,380,820
Restricted Stock Units [Abstract]
Restricted stock units vested over a period	4 years
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense	$ 1,110,166	$ 1,641,388
Research and Development [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense	5,385	4,671
Plasma Center Operating Expenses [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense	23,055	21,052
Selling, General and Administrative [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense	978,124	1,517,602
Cost of Product Revenue [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense	$ 103,602	$ 98,063
2022 Compensation Plan [Member]
Stock Options [Abstract]
Common stock, available for issuance (in shares)			18,000,000
Stock Options [Member]
Fair Value Assumptions and Methodology [Abstract]
Volatility	68.00%	68.00%
Dividend yield	0.00%	0.00%
Stock Options [Abstract]
Number of stock options granted (in shares)	1,727,510	1,194,032
Weighted average remaining contractual life of stock options, outstanding	6 years 7 months 6 days
Weighted average remaining contractual life of stock options, expected to vest	6 years 7 months 6 days
Weighted average remaining contractual life of stock options, exercisable	5 years 3 months 18 days
Common stock shares issued (in shares)	2,443
Stock Option, Shares [Abstract]
Options outstanding, vested and expected to vest, beginning balance (in shares)	8,256,211
Forfeited (in shares)	(15,555)
Expired (in shares)	(17,047)
Granted (in shares)	1,727,510
Exercised (in shares)	(5,416)
Options outstanding, vested and expected to vest, ending balance (in shares)	9,945,703
Options exercisable (in shares)	6,660,313
Stock Options, Weighted Average Exercise Price [Abstract]
Options outstanding, vested and expected to vest, weighted average exercise price, beginning balance (in dollars per share)	$ 3.37
Forfeited, weighted average exercise price (in dollars per share)	2.29
Expired, weighted average exercise price (in dollars per share)	7.06
Granted, weighted average exercise price (in dollars per share)	3.35
Exercised, weighted average exercise price (in dollars per share)	2.08
Options outstanding, vested and expected to vest, weighted average exercise price, ending balance (in dollars per share)	3.36
Options exercisable, weighted average exercise price (in dollars per share)	$ 3.67
Stock Options [Member] | Minimum [Member]
Fair Value Assumptions and Methodology [Abstract]
Expected term	5 years 6 months	5 years 6 months
Risk-free interest rate	4.20%	1.72%
Stock Options [Member] | Maximum [Member]
Fair Value Assumptions and Methodology [Abstract]
Expected term	6 years 3 months 18 days	6 years 3 months 18 days
Risk-free interest rate	4.24%	1.73%
Stock Options [Member] | Equity Incentive Plans [Member]
Stock Options, Weighted Average Exercise Price [Abstract]
Unrecognized compensation expense, stock options	$ 5,600,000
Unrecognized compensation expense recognition period	3 years
RSUs [Member]
Restricted Stock Units [Abstract]
Number of restricted stock units granted (in shares)	2,666,260	1,059,266
Shares withheld for tax withholding obligation (in shares)	185,068
Amount of shares withheld for tax withholding obligation	$ 600,000
Unvested RSU, Shares [Abstract]
Beginning balance (in shares)	2,866,987
Granted (in shares)	2,666,260
Vested (in shares)	(628,283)
Forfeited (in shares)	(29,500)
Ending balance (in shares)	4,875,464
Unvested RSU, Weighted Average Grant Date Fair Value
Unvested, Weighted average grant date fair value, beginning balance (in dollars per share)	$ 1.59
Granted, Weighted average grant date fair value (in dollars per share)	3.35
Vested, Weighted average grant date fair value (in dollars per share)	1.76
Forfeited, Weighted average grant date fair value (in dollars per share)	1.25
Unvested, Weighted average grant date fair value, ending balance (in dollars per share)	$ 2.53
RSUs [Member] | Directors [Member]
Restricted Stock Units [Abstract]
Restricted stock units vested over a period	1 year
RSUs [Member] | Employees [Member]
Restricted Stock Units [Abstract]
Restricted stock units vested over a period	4 years
RSUs [Member] | Equity Incentive Plans [Member]
Stock Options, Weighted Average Exercise Price [Abstract]
Unrecognized compensation expense recognition period	3 years 4 months 24 days
Unvested RSU, Weighted Average Grant Date Fair Value
Unrecognized compensation expense, non option	$ 12,000,000